Literature DB >> 19466313

[Model of experimental nonalcoholic steatohepatitis from use of methionine and choline deficient diet].

Idilio Zamin1, Angelo Alves de Mattos, Angelo Zambam de Mattos, Eduardo Migon, Ernesto Soares, Marcos Luiz Santos Perry.   

Abstract

CONTEXT: There are still many unknown aspects about nonalcoholic steatohepatitis, especially regarding its pathophysiology and pharmacological treatment. Thus, experimental models are important for a better understanding of this disease and the evaluation of the effects of drugs.
OBJECTIVE: To develop a model of experimental nonalcoholic steatohepatitis from use of methionine and choline deficient diet.
METHODS: Fifty Wistar male rats were studied. A methionine and choline deficient diet has been processed in a craft. A group of 40 animals received the deficient diet for 90 days, and a group of 10 rats (control group) received the standardized ration in the same period. After, the animals were killed by decapitation, and laparotomy was performed. Hepatectomy was performed and the liver was studied by macroscopy and microscopy. The level of significance considered was of 0,05.
RESULTS: The rats that received the deficient diet showed significant loss of weight with findings from malnutrition and all of them had at least some degree of macrovesicular steatosis. The diagnosis of nonalcoholic steatohepatitis was performed in 27 (70%) of the 39 rats that received this deficient diet (1 rat died during the study). None of the 10 rats that received the standardized diet had histological abnormalities.
CONCLUSION: The diet restricted in methionine and choline induced steatosis and steatohepatitis in an animal model with low cost.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466313     DOI: 10.1590/s0004-28032009000100017

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  4 in total

1.  Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β.

Authors:  Juliana Célia F Santos; Orlando R P de Araújo; Iara B Valentim; Kívia Queiroz de Andrade; Fabiana Andréa Moura; Salete Smaniotto; John Marques dos Santos; Juciano Gasparotto; Daniel P Gelain; Marília O F Goulart
Journal:  Oxid Med Cell Longev       Date:  2015-06-02       Impact factor: 6.543

2.  SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway.

Authors:  Jinhang Zhang; Yanping Li; Qinhui Liu; Rui Li; Shiyun Pu; Lina Yang; Yanhuan Feng; Liang Ma
Journal:  RSC Adv       Date:  2018-09-03       Impact factor: 4.036

3.  Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).

Authors:  Jin Ha Lee; Ji Young Oh; Soo Hyun Kim; In Jeong Oh; Yong-Ho Lee; Keun Woo Lee; Woong Hee Lee; Jeong-Hwan Kim
Journal:  Biomolecules       Date:  2020-10-08

4.  Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage.

Authors:  Shandiz Morega; Bogdan Cătălin; Cristiana Eugenia Simionescu; Konstantinos Sapalidis; Ion Rogoveanu
Journal:  Brain Sci       Date:  2021-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.